Sutro Biopharma Inc (STRO) Annual Balance Sheets

Annual · GAAP · USD millions
Access STRO quarterly Balance Sheets →
A period-by-period view of the balance sheet from Sutro Biopharma Inc to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent58.13
Marketable Securities, Current SH83.30
Cash & Short-term Investments141.00
Accounts receivable3.98
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.52
Total Current Assets150.93
Equipment/Property/Plant Net10.65
Long-term investments0.00
Other Assets, Noncurrent12.26
Equity Securities Fv Ni-
Restricted Cash Noncurrent0.86
Total Assets173.83
Liabilities
Accounts Payable, Current AC7.57
Accrued Liabilities, Current AC14.64
Debt, Current LI0.00
Other Liabilities, Current52.93
Total Current Liabilities75.13
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent231.15
Accrued Expenses And Other Current Liabilities34.58
Operating Lease Liability Current7.78
Contract With Customer Liability Noncurrent2.03
Deferred Royalty Obligation Related To Sale Of Future Royalties Noncurrent219.54
Total Liabilities306.28
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock845.48
Retained Earnings / Accumulated Deficit-977.96
Other Equity0.02
Common Stockholder's Equity-132.45
Total Stockholder's Equity-132.45
Liabilities & Stockholder's Equity173.83
4 historic quarters locked

Sign in to unlock the full Sutro Biopharma Inc balance sheet history.

About Sutro Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-119873

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.